IVIRMA Global is the world’s premier fertility group that leads the industry in research, success rates and patient care. From clinical excellence, to research and innovation, to teaching the next generation of reproductive endocrinologists, to advancing cutting edge protocols, standards and practices in the field.
The acronyms IVI and RMA represent the two best assisted reproduction groups in Europe and the U.S., respectively. Together, they have since the beginning of the nineties been setting the standard in the field of reproduction, until in February 2017 they decided to merge to form the largest Reproductive Medicine group in the world.
 
IVI was founded in 1990 by Professors José Remohí and Antonio Pellicer, and became a leader in fertility treatment in Europe and Latin America.
RMA was founded in 1999 by Drs. Paul Bergh, Richard Scott and Michael Drews, quickly becoming a leader in reproductive medicine in the United States.
 
IVI and RMA both place great importance on research, high-quality scientific results, and a common culture with a single objective: to achieve the best results for patients.

• 75 Clinical Offices & 28 Labs in 9 Countries
• +465 Physicians & Embryologists
• +2300 Employees
• +100 babies born daily thanks to IVIRMA

Research & Development…
• +2500 Publications
• 69 Researchers
• 7 Researcher centers


Fertility

IVI RMA GLOBAL

Javier Sánchez-Prieto

Iris G.

Claire Robinson

Antonio Pellicer

Nicolás Naranjo

Mikel Carricas

Juan Antonio García Velasco

Blasco De Felice

Miguel Tablado

Max Marsden

Lynn Mason

Francisco Jiménez

Antonio Requena

Research and Laboratory Team

Business and Support Services

Global Management Committee

Human Resources and Recruitment

Healthcare and Medical

Finance and Accounting

Marketing and Communications Team

Leadership Team

Technology and Product Development

Teams at IVI RMA GLOBAL